SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-017996
Filing Date
2018-07-31
Accepted
2018-07-31 08:30:49
Documents
40
Period of Report
2018-07-27
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kalv-8k_20180727.htm 8-K 36211
2 EX-99.1 kalv-ex991_6.htm EX-99.1 148035
3 EX-99.2 kalv-ex992_8.htm EX-99.2 31736
4 GRAPHIC g2mlnvlh2z5u000014.jpg GRAPHIC 160038
5 GRAPHIC g2mlnvlh2z5u000020.jpg GRAPHIC 173950
6 GRAPHIC g2mlnvlh2z5u000027.jpg GRAPHIC 185631
7 GRAPHIC g2mlnvlh2z5u000012.jpg GRAPHIC 119452
8 GRAPHIC g2mlnvlh2z5u000011.jpg GRAPHIC 216761
9 GRAPHIC g2mlnvlh2z5u000023.jpg GRAPHIC 133255
10 GRAPHIC g2mlnvlh2z5u000022.jpg GRAPHIC 160479
11 GRAPHIC g2mlnvlh2z5u000008.jpg GRAPHIC 224574
12 GRAPHIC g2mlnvlh2z5u000026.jpg GRAPHIC 204183
13 GRAPHIC g2mlnvlh2z5u000018.jpg GRAPHIC 198540
14 GRAPHIC g2mlnvlh2z5u000009.jpg GRAPHIC 137793
15 GRAPHIC g2mlnvlh2z5u000007.jpg GRAPHIC 133103
16 GRAPHIC g2mlnvlh2z5u000021.jpg GRAPHIC 186653
17 GRAPHIC g2mlnvlh2z5u000017.jpg GRAPHIC 162068
18 GRAPHIC g2mlnvlh2z5u000003.jpg GRAPHIC 170649
19 GRAPHIC g2mlnvlh2z5u000002.jpg GRAPHIC 368739
20 GRAPHIC g2mlnvlh2z5u000029.jpg GRAPHIC 179922
21 GRAPHIC g2mlnvlh2z5u000006.jpg GRAPHIC 167223
22 GRAPHIC g2mlnvlh2z5u000015.jpg GRAPHIC 178337
23 GRAPHIC g2mlnvlh2z5u000032.jpg GRAPHIC 142442
24 GRAPHIC g2mlnvlh2z5u000013.jpg GRAPHIC 136319
25 GRAPHIC g2mlnvlh2z5u000035.jpg GRAPHIC 125722
26 GRAPHIC g2mlnvlh2z5u000025.jpg GRAPHIC 151401
27 GRAPHIC g2mlnvlh2z5u000033.jpg GRAPHIC 197306
28 GRAPHIC g2mlnvlh2z5u000016.jpg GRAPHIC 150464
29 GRAPHIC g2mlnvlh2z5u000036.jpg GRAPHIC 86628
30 GRAPHIC g2mlnvlh2z5u000030.jpg GRAPHIC 177048
31 GRAPHIC g2mlnvlh2z5u000005.jpg GRAPHIC 114946
32 GRAPHIC g2mlnvlh2z5u000010.jpg GRAPHIC 109869
33 GRAPHIC g2mlnvlh2z5u000001.jpg GRAPHIC 96738
34 GRAPHIC g2mlnvlh2z5u000019.jpg GRAPHIC 138483
35 GRAPHIC g2mlnvlh2z5u000024.jpg GRAPHIC 168120
36 GRAPHIC gota0uanshow000001.jpg GRAPHIC 5519
37 GRAPHIC g2mlnvlh2z5u000004.jpg GRAPHIC 147387
38 GRAPHIC g2mlnvlh2z5u000034.jpg GRAPHIC 211596
39 GRAPHIC g2mlnvlh2z5u000031.jpg GRAPHIC 184114
40 GRAPHIC g2mlnvlh2z5u000028.jpg GRAPHIC 127034
  Complete submission text file 0001564590-18-017996.txt   8393115
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-36830 | Film No.: 18979539
SIC: 2834 Pharmaceutical Preparations